Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Other3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

Role of TMEM219 Marker in Type 1 Diabetes
Diabetes Mellitus
PrincipalinvestigatorStart date: 2020-08-08
Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus
AlbuminuriaDiet, HealthyRenal Function Disorder+1 more
PrincipalinvestigatorStart date: 2019-05-06
NCT04365517Phase 3Unknown
The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
CKDCovid19Diabetes Mellitus, Type 2
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03794739PrincipalInvestigator

Role of TMEM219 Marker in Type 1 Diabetes

Diabetes Mellitus
Unknown
NCT04272359PrincipalInvestigator

Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus

AlbuminuriaDiet, HealthyRenal Function Disorder+1 more
Unknown
NCT04365517Phase 3PrincipalInvestigator

The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients

CKDCovid19Diabetes Mellitus, Type 2
Unknown

All 3 trials loaded